✦ LIBER ✦

Heat shock protein 70 gene therapy combined with hyperthermia using magnetic nanoparticles

✍ Scribed by Ito, Akira; Matsuoka, Fumiko; Honda, Hiroyuki; Kobayashi, Takeshi

Book ID: 110019054
Publisher: Nature Publishing Group
Year: 2003
Tongue: English
Weight: 214 KB
Volume: 10
Category: Article
ISSN: 0929-1903
DOI: 10.1038/sj.cgt.7700648

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antitumor effects of combined therapy of

Antitumor effects of combined therapy of recombinant heat shock protein 70 and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma

✍ Akira Ito; Fumiko Matsuoka; Hiroyuki Honda; Takeshi Kobayashi 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 281 KB

Heat-inducible TNF-α gene therapy combin

Heat-inducible TNF-α gene therapy combined with hyperthermia using magnetic nanoparticles as a novel tumor-targeted therapy

✍ Ito, Akira; Shinkai, Masashige; Honda, Hiroyuki; Kobayashi, Takeshi 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 579 KB

Heat shock protein 70 expression induces

Heat shock protein 70 expression induces antitumor immunity during intracellular hyperthermia using magnetite nanoparticles

✍ Akira Ito; Masashige Shinkai; Hiroyuki Honda; Kazuhiro Yoshikawa; Shinsuke Saga; 📂 Article 📅 2003 🏛 Springer-Verlag 🌐 English ⚖ 499 KB

Cancer immunotherapy based on intracellu

Cancer immunotherapy based on intracellular hyperthermia using magnetite nanoparticles: a novel concept of “heat-controlled necrosis” with heat shock protein expression

✍ Akira Ito; Hiroyuki Honda; Takeshi Kobayashi 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 515 KB

Differential sensitivity of leukemic and

Differential sensitivity of leukemic and normal hematopoietic progenitors to the killing effect of hyperthermia and quercetin used in combination: Role of heat-shock protein-70

✍ Luigi M. Larocca; Franco O. Ranelletti; Nicola Maggiano; Sergio Rutella; Elettra 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 335 KB 👁 2 views

Autologous bone-marrow transplantation (ABMT) is widely used in the treatment of acute leukemias where a matched sibling donor is not available for allogeneic transplantation. However, a major problem in ABMT is relapse, and ex vivo purging may be very important in preventing it. We show here that q